India’s Drug Industry Worries Whether New Pricing Policy Robust Enough
This article was originally published in PharmAsia News
Executive Summary
Some of the largest brands are faced with losing their sheen as debate heats up in the drug industry over whether the new Indian drug pricing system is robust enough to deliver needed reform.